Carlsmed Inc. has announced the publication of a new retrospective cohort study in the Global Spine Journal evaluating the impact of 3D preoperative planning combined with patient-specific, anatomically designed interbody implants in complex adult spinal deformity (ASD) surgery. The study compared 2-year revision rates among ASD patients treated with Carlsmed’s aprevo® personalized interbody implants to those receiving conventional stock implants. Results showed that patients who received aprevo® implants had a significantly lower revision rate due to mechanical complications (4.3%, n=115) compared to those treated with stock devices (16.6%, n=997), representing a 74% relative reduction (p<0.001). These findings have already been published.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carlsmed Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9621017-en) on January 06, 2026, and is solely responsible for the information contained therein.